• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌放疗后鼻咽坏死患者的微生物病因及药敏情况

Microbial etiology, susceptibility profile of postradiation nasopharyngeal necrosis patients with nasopharyngeal carcinoma.

作者信息

Wang Li, Yang Jun, Peng Shi-Yi, Li Guo-Qing, Tu Zi-Wei

机构信息

Department of Radiotherapy, Eye Ear Nose and Throat Hospital, Shanghai Medical College, Fudan University, Shanghai, PR China.

Department of Radiotherapy, Medical College, Nanchang University, Nanchang, PR China.

出版信息

Cancer Radiother. 2020 Apr;24(2):93-98. doi: 10.1016/j.canrad.2019.09.008. Epub 2020 Feb 11.

DOI:10.1016/j.canrad.2019.09.008
PMID:32057645
Abstract

OBJECTIVE

Postradiation nasopharyngeal necrosis (PRNN) is a notorious complication after radiotherapy that affects prognosis in patients with nasopharyngeal carcinoma (NPC). It is important for clinical doctors to realize this problem in order to cope with this severe clinical situation. The aim of our study was to assess the bacteriology of PRNN and to demonstrate the antimicrobial susceptibility pattern that should guide the clinicians towards more appropriate antibiotic use.

METHODS

Sixty-nine NPC patients with PRNN in our department between March 2013 and December 2017 were retrospectively enrolled. Pathogenic culture and drug sensitivity test were performed in these 69 NPC patients with PRNN. The infection rate of Pathogens and the sensitivity of the drugs were analyzed based on these results.

RESULTS

Sixty-nine NPC patients with PRNN were enrolled in our study. Pathogens were identified in 58 (84%) patients. Of the 58 patients, Staphylococcus aureus was isolated in 34 (58.6%) patients. And the second most common group of bacterial isolates was Pseudomonas aeruginosa. Antibiotic sensitivity showed that Levofloxacin was the highest (88.5%), followed by Ciprofloxacin (85.2%) and Gentamicin (80.3%). The only pathologic fungus was Candidaalbicans, about 6.8%. The positive rates of bacterial and fungal culture in PRNN patients were not significantly different from the patients' gender, age, stage, number of radiotherapy courses (P>0.05), but the cure rate was statistically higher in culture-negative patients in comparison with culture-positive patients (63.6% vs 20.7%, P=0.011).

CONCLUSION

Our results provide an overall picture of the microbiology and drug susceptibility patterns for NPC patients with PRNN and could help implement guidelines for more rational treatment and improve therapeutic outcome.

摘要

目的

放疗后鼻咽坏死(PRNN)是鼻咽癌(NPC)放疗后一种严重的并发症,影响患者预后。临床医生认识到这一问题对于应对这一严峻的临床情况很重要。本研究旨在评估PRNN的细菌学情况,并展示抗菌药敏模式,以指导临床医生更合理地使用抗生素。

方法

回顾性纳入2013年3月至2017年12月在我科就诊的69例患有PRNN的NPC患者。对这69例患有PRNN的NPC患者进行病原菌培养和药敏试验。根据这些结果分析病原菌的感染率和药物敏感性。

结果

本研究纳入了69例患有PRNN的NPC患者。58例(84%)患者鉴定出病原菌。在这58例患者中,34例(58.6%)分离出金黄色葡萄球菌。第二常见的细菌分离菌群是铜绿假单胞菌。抗生素敏感性显示左氧氟沙星最高(88.5%),其次是环丙沙星(85.2%)和庆大霉素(80.3%)。仅有一种病理真菌为白色念珠菌,约占6.8%。PRNN患者的细菌和真菌培养阳性率在患者性别、年龄、分期、放疗疗程数方面无显著差异(P>0.05),但培养阴性患者的治愈率与培养阳性患者相比有统计学意义上的升高(63.6%对20.7%,P=0.011)。

结论

我们的结果提供了患有PRNN的NPC患者的微生物学和药敏模式的总体情况,有助于实施更合理的治疗指南并改善治疗效果。

相似文献

1
Microbial etiology, susceptibility profile of postradiation nasopharyngeal necrosis patients with nasopharyngeal carcinoma.鼻咽癌放疗后鼻咽坏死患者的微生物病因及药敏情况
Cancer Radiother. 2020 Apr;24(2):93-98. doi: 10.1016/j.canrad.2019.09.008. Epub 2020 Feb 11.
2
Postradiation nasopharyngeal necrosis in the patients with nasopharyngeal carcinoma.鼻咽癌患者放疗后鼻咽坏死
Head Neck. 2009 Jun;31(6):807-12. doi: 10.1002/hed.21036.
3
Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients.鼻咽癌放疗后咽旁组织坏死的临床特征及其手术干预后的转归。
Oral Oncol. 2021 Mar;114:105180. doi: 10.1016/j.oraloncology.2021.105180. Epub 2021 Jan 23.
4
[Clinical analysis of 60 cases with radiative nasopharyngeal necrosis in nasopharyngeal carcinoma].鼻咽癌放射性鼻咽坏死60例临床分析
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Mar;47(3):185-90.
5
Assessment of Prophylactic Internal Carotid Artery Management in Postradiation Nasopharyngeal Necrosis Patients.评估放射性鼻咽坏死患者的预防性颈内动脉处理。
Otolaryngol Head Neck Surg. 2024 Feb;170(2):447-456. doi: 10.1002/ohn.615. Epub 2023 Dec 17.
6
Proposal for a new risk classification system for nasopharyngeal carcinoma patients with post-radiation nasopharyngeal necrosis.针对放疗后鼻咽癌坏死患者的新风险分类系统提案。
Oral Oncol. 2017 Apr;67:83-88. doi: 10.1016/j.oraloncology.2017.02.012. Epub 2017 Feb 20.
7
Deep radiation-induced ulcer following nasopharyngeal carcinoma: surgical management.鼻咽癌放疗后深部溃疡:手术治疗
BMJ Case Rep. 2019 Nov 5;12(11):e230700. doi: 10.1136/bcr-2019-230700.
8
Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis.67例鼻咽癌放疗后鼻咽坏死患者的临床发现及影像学特征
Chin J Cancer. 2013 Oct;32(10):533-8. doi: 10.5732/cjc.012.10252. Epub 2013 Jul 2.
9
Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.调强放疗治疗初诊鼻咽癌后发生的放射性鼻咽坏死(INN):临床特征及治疗策略的影响。
Radiat Oncol. 2022 Jan 21;17(1):13. doi: 10.1186/s13014-022-01980-0.
10
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.放射组学特征揭示了与再放疗鼻咽癌组织耐受和生存相关的多尺度肿瘤异质性:一项多中心研究。
BMC Med. 2023 Nov 27;21(1):464. doi: 10.1186/s12916-023-03164-3.

引用本文的文献

1
Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.调强放疗治疗初诊鼻咽癌后发生的放射性鼻咽坏死(INN):临床特征及治疗策略的影响。
Radiat Oncol. 2022 Jan 21;17(1):13. doi: 10.1186/s13014-022-01980-0.